These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22110158)

  • 1. A novel technology to screen for cognitive impairment in the elderly.
    Wright DW; Nevárez H; Kilgo P; LaPlaca M; Robinson A; Fowler S; Brumfield J; Goldstein FC
    Am J Alzheimers Dis Other Demen; 2011 Sep; 26(6):484-91. PubMed ID: 22110158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a novel technology for presenting screening measures to detect mild cognitive impairment in elderly patients.
    Wright DW; Goldstein FC; Kilgo P; Brumfield JR; Ravichandran T; Danielson ML; Laplaca M
    Int J Clin Pract; 2010 Aug; 64(9):1190-7. PubMed ID: 20497262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Outcome and cognitive changes of mild cognitive impairment in the elderly: a follow-up study of 47 cases].
    Xiao SF; Xue HB; Li GJ; Li CB; Wu WY; Zhang MY
    Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(21):1441-6. PubMed ID: 16842692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do the ABCS 135 short cognitive screen and its subtests discriminate between normal cognition, mild cognitive impairment and dementia?
    Standish TI; Molloy DW; Cunje A; Lewis DL
    Int J Geriatr Psychiatry; 2007 Mar; 22(3):189-94. PubMed ID: 16977680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening of mild cognitive impairment in Chinese older adults--a multistage validation of the Chinese abbreviated mild cognitive impairment test.
    Lam LC; Tam CW; Lui VW; Chan WC; Chan SS; Chiu HF; Leung T; Tham MK; Ho KS; Chan WM
    Neuroepidemiology; 2008; 30(1):6-12. PubMed ID: 18204291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical prediction of Alzheimer disease dementia across the spectrum of mild cognitive impairment.
    Dickerson BC; Sperling RA; Hyman BT; Albert MS; Blacker D
    Arch Gen Psychiatry; 2007 Dec; 64(12):1443-50. PubMed ID: 18056553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the clock drawing test appropriate for screening for mild cognitive impairment?--Results of the German study on Ageing, Cognition and Dementia in Primary Care Patients (AgeCoDe).
    Ehreke L; Luppa M; Luck T; Wiese B; Weyerer S; Eifflaender-Gorfer S; Weeg D; Olbrich J; van den Bussche H; Bachmann C; Eisele M; Maier W; Jessen F; Wagner M; Fuchs A; Pentzek M; Angermeyer MC; König HH; Riedel-Heller SG;
    Dement Geriatr Cogn Disord; 2009; 28(4):365-72. PubMed ID: 19887799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CAMcog as a screening tool for diagnosis of mild cognitive impairment and dementia in a Brazilian clinical sample of moderate to high education.
    Nunes PV; Diniz BS; Radanovic M; Abreu ID; Borelli DT; Yassuda MS; Forlenza OV
    Int J Geriatr Psychiatry; 2008 Nov; 23(11):1127-33. PubMed ID: 18464287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of neuropsychological tests for the diagnosis of dementia: a survey of Italian memory clinics.
    Di Pucchio A; Vanacore N; Marzolini F; Lacorte E; Di Fiandra T; ; Gasparini M
    BMJ Open; 2018 Mar; 8(3):e017847. PubMed ID: 29599390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the memory performance index with standard neuropsychological measures of cognition.
    Rafii MS; Taylor C; Coutinho A; Kim K; Galasko D
    Am J Alzheimers Dis Other Demen; 2011 May; 26(3):235-9. PubMed ID: 21406427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A subtest analysis of the Montreal cognitive assessment (MoCA): which subtests can best discriminate between healthy controls, mild cognitive impairment and Alzheimer's disease?
    Cecato JF; Martinelli JE; Izbicki R; Yassuda MS; Aprahamian I
    Int Psychogeriatr; 2016 May; 28(5):825-32. PubMed ID: 26620850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognitive testing supports a broader concept of mild cognitive impairment.
    Gualtieri CT; Johnson LG
    Am J Alzheimers Dis Other Demen; 2005; 20(6):359-66. PubMed ID: 16396441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total scores of the CERAD neuropsychological assessment battery: validation for mild cognitive impairment and dementia patients with diverse etiologies.
    Seo EH; Lee DY; Lee JH; Choo IH; Kim JW; Kim SG; Park SY; Shin JH; Do YJ; Yoon JC; Jhoo JH; Kim KW; Woo JI
    Am J Geriatr Psychiatry; 2010 Sep; 18(9):801-9. PubMed ID: 20220577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can a direct IADL measure detect deficits in persons with MCI?
    Binegar DL; Hynan LS; Lacritz LH; Weiner MF; Cullum CM
    Curr Alzheimer Res; 2009 Feb; 6(1):48-51. PubMed ID: 19199874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Diagnostic and Prognostic Value of Neuropsychological Assessment in Memory Clinic Patients.
    Jansen WJ; Handels RL; Visser PJ; Aalten P; Bouwman F; Claassen J; van Domburg P; Hoff E; Hoogmoed J; Leentjens AF; Rikkert MO; Oleksik AM; Smid M; Scheltens P; Wolfs C; Verhey F; Ramakers IH
    J Alzheimers Dis; 2017; 55(2):679-689. PubMed ID: 27716658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brief Memory and Executive Test: evaluation of a new screening test for cognitive impairment due to small vessel disease.
    Brookes RL; Hannesdottir K; Lawrence R; Morris RG; Markus HS
    Age Ageing; 2012 Mar; 41(2):212-8. PubMed ID: 22267862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical dementia: an Italian multicentre study on amnestic mild cognitive impairment.
    Perri R; Serra L; Carlesimo GA; Caltagirone C;
    Dement Geriatr Cogn Disord; 2007; 23(5):289-300. PubMed ID: 17356272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for mild cognitive impairment (MCI) utilizing combined mini-mental-cognitive capacity examinations for identifying dementia prodromes.
    Xu G; Meyer JS; Thornby J; Chowdhury M; Quach M
    Int J Geriatr Psychiatry; 2002 Nov; 17(11):1027-33. PubMed ID: 12404652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for amnestic mild cognitive impairment and early Alzheimer's disease with M@T (Memory Alteration Test) in the primary care population.
    Rami L; Molinuevo JL; Sanchez-Valle R; Bosch B; Villar A
    Int J Geriatr Psychiatry; 2007 Apr; 22(4):294-304. PubMed ID: 16998781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes over time in memory, processing speed and clock drawing tests help to discriminate between vascular cognitive impairment, mild cognitive impairment and Alzheimer's disease.
    de Jager CA
    Neurol Res; 2004 Jul; 26(5):481-7. PubMed ID: 15362213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.